Legal Representation
Attorney
Mark J. Liss
USPTO Deadlines
Next Deadline
1708 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240820)
Due Date
August 20, 2030
Grace Period Ends
February 20, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
31 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 20, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 20, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 4, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 4, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 29, 2024 | ATRV | O | ATTORNEY REVIEW COMPLETED | Loading... |
| May 29, 2024 | ATRV | O | ATTORNEY REVIEW COMPLETED | Loading... |
| May 15, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 2, 2024 | OTHE | I | CASE RETURNED TO EXAMINATION | Loading... |
| May 2, 2024 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Apr 25, 2024 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Apr 25, 2024 | PCBG | O | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | Loading... |
| Apr 23, 2024 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Mar 29, 2024 | TPAD | I | TEAS PETITION TO AMEND BASIS RECEIVED | Loading... |
| Jan 23, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 19, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 19, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 19, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 25, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 30, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 30, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 10, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 26, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 21, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 21, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 21, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 5, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 5, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 5, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 16, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 16, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Implantable medicines for treating neurological disorders and muscle dystonia; implantable antiaging medicines, namely, botulinum toxin for medical use for treatment of facial wrinkles; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, neuropathy pain and pelvic pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, neuropathy pain and pelvic pain
Additional Information
Translation
The wording "LUVANTAS" has no meaning in a foreign language
Classification
International Classes
005